Skip to content
10-Q

Quarterly Report

CORTRONIX BIOMEDICAL ADVANCEMENT TECHNOLOGIES INC.

0001594062-14-000252

← back to feed
Filed
Aug 1, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Jul 31, 2014 349.5M sh
Shares Diluted Q3 2014 · May 31, 2014 349.5M sh
Shares Diluted Q3 2014 · May 31, 2014 331.18M sh
Shares Diluted Q3 2014 · May 31, 2013 287M sh
Shares Diluted Q3 2014 · May 31, 2013 282.49M sh
Operating Cash Flow Q3 2014 · May 31, 2014 −$31.18K
Operating Cash Flow Q3 2014 · May 31, 2013 −$280.53K
Cash And Equivalents Q3 2014 · May 31, 2014 $760
Cash And Equivalents Q3 2014 · Aug 31, 2013 $640
Cash And Equivalents Q3 2014 · May 31, 2013 $22
Cash And Equivalents Q3 2014 · Aug 31, 2012 $31.69K
Stockholders Equity Q3 2014 · May 31, 2014 −$1.26M
Stockholders Equity Q3 2014 · Aug 31, 2013 −$1.05M
Current Liabilities Q3 2014 · May 31, 2014 $1.33M
Current Liabilities Q3 2014 · Aug 31, 2013 $1.14M
Current Assets Q3 2014 · May 31, 2014 $61.14K
Current Assets Q3 2014 · Aug 31, 2013 $61.02K
Total Assets Q3 2014 · May 31, 2014 $77.11K
Total Assets Q3 2014 · Aug 31, 2013 $85.37K
Sga Expense Q3 2014 · May 31, 2014 $10.49K
Sga Expense Q3 2014 · May 31, 2014 $26K
Sga Expense Q3 2014 · May 31, 2013 $23.31K
Sga Expense Q3 2014 · May 31, 2013 $81.76K
Net Income Q3 2014 · May 31, 2014 −$80.39K
Net Income Q3 2014 · May 31, 2014 −$5.21M
Net Income Q3 2014 · May 31, 2013 −$112.64K
Net Income Q3 2014 · May 31, 2013 −$331.22K
Operating Income Q3 2014 · May 31, 2014 −$58.76K
Operating Income Q3 2014 · May 31, 2014 −$4.38M
Operating Income Q3 2014 · May 31, 2013 −$92.35K
Operating Income Q3 2014 · May 31, 2013 −$277.3K